- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.04. | Solventum gets the ball rolling after 3M spinout | ||
| 02.04. | Abbott's TriClip heart implant receives FDA approval for tricuspid valve repair | ||
| 02.04. | J&J targets rare maternal-fetal diseases: 'We're going for this. No one else has.' | ||
| 02.04. | Roivant's inflammatory med gets back on track with phase 2 eye disease data | ||
| 02.04. | Gilead dives deeper into Nurix protein degrader collab, paying $15M for 2-year extension | ||
| 02.04. | Ipsen joins ADC race via $900M biobuck deal with Sutro, chasing same target as Merck, Boehringer | ||
| 02.04. | Gritstone ground down by phase 2 cancer vaccine fail, sparking race against cash to gather more data | ||
| 01.04. | 'One-two punch' of epigenetic cancer drugs could knock out colorectal cancer cells | ||
| 01.04. | Carisma lets go of 37% of staff, CAR-M candidate to stretch cash runway | ||
| 01.04. | ZimVie begets Highridge Medical with completed spine business spinout | ||
| 01.04. | Equillium's lupus drug improves kidney biomarker, teeing up opt-in decision from Ono | ||
| 01.04. | Abbott advances its hand-held, rapid blood test for TBI, concussions with new FDA clearance | ||
| 29.03. | Lung cancer startup Maverix Medical snaps up diagnostic developer Cirrus Bio | ||
| 29.03. | InfuTronix pulls 52,000 infusion pumps from the market, pending design overhaul | ||
| 29.03. | ProJenX ALS treatment gets back on the map after partial FDA hold | ||
| 29.03. | FDA decision delay for Applied Tx rare disease drug sends biotech's stock tumbling after hours | ||
| 28.03. | Ypsomed hands off insulin pen needle business to focus on smart pump, autoinjector development | ||
| 28.03. | Exact Sciences posts positive data for its capsule-on-a-string test for esophageal cancer | ||
| 28.03. | Milestone resubmits new drug application while Aldeyra readies similar 2nd-chance filing | ||
| 28.03. | Ironwood spies new frontier for $1B GLP-2 analog in exploratory phase 2 rare disease trial | ||
| 28.03. | Avalo signals change in fortunes by snapping up AlmataBio for ex-Lilly inflammatory drug | ||
| 28.03. | Gilead pays $43.5M for early-phase IL-12 prospect from Xilio as biotech reduces head count | ||
| 28.03. | Boundless Bio boldly goes public with $100M IPO | ||
| 27.03. | GAO report: FDA should inspect hiring practices as it struggles to find and keep investigators | ||
| 27.03. | Moderna's early vaccine pipeline underpinned by Epstein-Barr, norovirus and shingles prospects |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
